ArQule | Stock Discussion Forums

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Biotech / Medical
ArQule

An SI Board Since December 1996

Posts	SubjectMarks	Bans	Symbol
399	14	0	ARQL

Emcee: noronha	Type: Unmoderated

Introduction Market Data Compact

Go to reply# or date (mm/dd/yy):

Reply	Message Preview	From	Recs	Posted
99	I am The Prophet only in areas where I have insight. This is not one of them.	The Prophet	-	9/16/1997
98	I have zero expertise in biotechnology, although my reverse transcriptase might	The Prophet	-	9/16/1997
97	The year 2010 should be about right. Sell when you feel the time is correct.	scaram(o)uche	-	9/15/1997
96	Prophet, Shouldn't we be asking you when its time to sell? I hold share	James Silverman	-	9/15/1997
95	The insider selling was expected with the lock-up expiration. The Director is o	Dr. John M. de Castro	-	9/15/1997
94	Do you think it's time to sell?	The Prophet	-	9/15/1997
93	More insider selling announced during the week of 9/12: President and a direct	Czechsinthemail	-	9/15/1997
92	Any thoughts as to strong move recently? Has H&Q reaffirmed its recommendat	Larry Liebman	-	9/11/1997
91	Insider sales reported week of 9/5/97: 1 director sold 92,500 shares @$16.32 -	Czechsinthemail	-	9/6/1997
90	Bill...... in addition to the stuff I sent in email, you might poke around an	scaram(o)uche	-	7/20/1997
89	Tough disease, as you know. While I'm not nuts about cancer vaccines, you	scaram(o)uche	-	7/19/1997
88	Bill, Several links which will help you in research: text.nlm.nih.gov pharmin	Miljenko Zuanic	-	7/19/1997
87	Richard, (and DavidS., Miljenko, John, et al.)...a dear friend has just been di	WWS	-	7/19/1997
86	Cheers Rick, James! Rick, No I don't think so. As you said they have enoug	Miljenko Zuanic	-	7/18/1997
85	Miljenko, ARQL is doing all these collaborations because their technology is	James Silverman	-	7/18/1997
84	Good question. Theoretically, money can accomodate productive growth. But, you	scaram(o)uche	-	7/18/1997
83	Rick, Is ARQL diluting, raning out of focus, with all this collaborations? F	Miljenko Zuanic	-	7/17/1997
82	Wally...... this is biotech. Nobody gives a damn about quarterly estimates f	scaram(o)uche	-	7/17/1997
81	The June quarter for ARQL in terms of eps is 99.44% irrelevant. (I promise)	David S.	-	7/17/1997
80	ARQL 2Q97 EPS = -$.04. May lead to a price decline ? (-$.02 expected) See r	Wally Mastroly	-	7/17/1997
79	It isn't a stretch to assume that AGPH employees/consultants, etc. post com	David S.	-	7/15/1997
78	I have never consulted for AGPH or received a dime from them for any reason. I	scaram(o)uche	-	7/15/1997
77	So, it is possible that you have in the past received money from Agouron, or po	David S.	-	7/15/1997
76	David, I'm a consultant, and you run a hedge fund. I'm even affordable	scaram(o)uche	-	7/14/1997
75	David-didnt know you bought stocks :-) I don't know the specifics but I do	James Silverman	-	7/11/1997

Go to reply# or date (mm/dd/yy):